TY  - JOUR
AU  - Hey-Hadavi, Juliana
AU  - Seekins, Daniel
AU  - Palmer, Melissa
AU  - Coffey, Denise
AU  - Caminis, John
AU  - Abdullaev, Sandzhar
AU  - Patwardhan, Meenal
AU  - Tyler, Haifa
AU  - Raheja, Ritu
AU  - Stanley, Ann Marie
AU  - Pineda-Salgado, Liliam
AU  - Bourdet, David L
AU  - Andrade, Raul J
AU  - Hayashi, Paul H
AU  - Dimick-Santos, Lara
AU  - Rockey, Don C
AU  - Estilo, Alvin
PY  - 2021
DO  - 10.1007/s40264-021-01051-5
UR  - http://hdl.handle.net/10668/17356
T2  - Drug safety
AB  - Causality assessment for suspected drug-induced liver injury (DILI) during drug development and following approval is challenging. The IQ DILI Causality Working Group (CWG), in collaboration with academic and regulatory subject matter experts (SMEs),...
LA  - en
KW  - Causality
KW  - Chemical and Drug Induced Liver Injury
KW  - Clinical Trials as Topic
KW  - Data Collection
KW  - Expert Testimony
KW  - Humans
TI  - Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials.
TY  - research article
VL  - 44
ER  -